ArticleCellular oncology (Dordrecht, Netherlands)2023

MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer.

Sung-Hsin Kuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.